Joseph Eid
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph Eid
The proxy statement of Geron Corp reports total compensation of $1,001,052 for Joseph Eid in fiscal 2025, including a base salary of $650,000. Disclosed compensation is on record for 2 fiscal years. Joseph Eid has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for Geron Corp on September 15, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Geron Corp (GERN)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Geron Corp
Other people whose current roles at this company are on record from its filings.
- Dawn C. Bir CEO, Board Member
- Elizabeth G. O'Farrell Chairman, Board Member
- Michelle J. Robertson CFO
- Shanthakumar Tyavanagimatt CTO
- Constantine Chinoporos Board Member
- Elizabeth G. O’Farrell Board Member
- Gaurav Aggarwal, M.D. Board Member
- Harout Semerjian Board Member
- John A. Scarlett, M.D. Board Member
- John F. McDonald Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Geron Corp (GERN) | Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024) | $650,000 | $1,001,052 |
| 2024 | Geron Corp (GERN) | Executive Vice President, Research & Development (as of November 11, 2024) | $93,750 | $7,762,848 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.